← FDA DRUG APPROVALS

FDA ANDA · ANDA084072

TRIAMCINOLONE DIACETATE

Sponsor: WATSON LABS

APPLICATION
ANDA084072
TYPE
ANDA
ORIGINAL APPROVAL
1977-01-24
LATEST ACTION
1999-02-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE DIACETATEDiscontinued
TRIAMCINOLONE DIACETATE 40MG/ML · INJECTABLE · INJECTION

Approval history

1999-02-19Manufacturing (CMC) · Supplement 166AP
1999-02-02Manufacturing (CMC) · Supplement 164AP
1998-05-27Manufacturing (CMC) · Supplement 163AP
1996-04-01Manufacturing (CMC) · Supplement 161AP
1996-04-01Labeling · Supplement 162AP
1996-04-01Manufacturing (CMC) · Supplement 160AP
1995-01-12Labeling · Supplement 159AP
1994-01-06Labeling · Supplement 157AP
1991-10-04Manufacturing (CMC) · Supplement 155AP
1991-10-04Manufacturing (CMC) · Supplement 158AP
1991-08-15Labeling · Supplement 156AP
1989-11-09Labeling · Supplement 150AP
1988-12-30Bioequivalence · Supplement 153AP
1988-12-23Manufacturing (CMC) · Supplement 152AP
1988-12-23Manufacturing (CMC) · Supplement 151AP
1986-06-16Manufacturing (CMC) · Supplement 147AP
1977-01-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →